Clinical Trial

Singing Intervention for Chronic Obstructive Pulmonary Disease (COPD)

Study acronym: EMPOWER
Completed
View on ClinicalTrials.gov →
Summary
Why is this study being done? Chronic Obstructive Pulmonary Disease (COPD) causes airflow blockage creating breathing issues, distress, and lower well-being. COPD also causes hyperinflation of the lungs. The investigators are doing the study to learn more about improving lung function for patients with COPD by using voice-based experiences. What is being tested in this study? If singing/vocalizing can improve lung function. How long will I be in the study? The study will last 4 weeks and involve 2 in-person visits to KUMC with virtual vocal sessions two times a week over Zoom.
Trial Details
NCT Number NCT07563283
Lead Sponsor University of Kansas Medical Center
Conditions COPD (Chronic Obstructive Pulmonary Disease)
Enrollment 5 participants
Start Date 2024-07-25
Primary Completion 2024-11-26 (estimated)
Study Completion 2024-11-26 (estimated)
Updated on ClinicalTrials.gov 2026-05-04